Nicole M Bouvier, MD
- ASSOCIATE PROFESSOR | Medicine, Infectious Diseases
- ASSOCIATE PROFESSOR | Microbiology
Research Topics:Antivirals, Drug Resistance, Immunology, Infectious Disease, Influenza Virus, Viruses and Virology
Nicole M. Bouvier, M.D., specializes in the diagnosis and treatment of infectious diseases in hospitalized patients.
Her research focuses on the host, viral, and environmental factors that affect the respiratory transmission of influenza viruses. For more information, please visit the Bouvier lab website.
American Board of Internal Medicine
- General Infectious Diseases
Multi-Disciplinary Training AreaMicrobiology [MIC]
BA Magna Cum Laude, Williams College
Certificate, Columbia University Post-Baccalaureate Premedical Program
MD with Distinction in Research, Mount Sinai School of Medicine
MD, Mount Sinai School of Medicine
Residency, Internal Medicine, Mount Sinai Hospital
Fellowship, Infectious Disease, Mount Sinai Hospital
Sir William Osler Young Investigator Award
Alpha Omega Alpha
Special Citation for Fellows-in-Training
Distinction in Research
Phi Beta Kappa
The Bouvier Lab studies host and viral factors that affect the respiratory transmission of influenza viruses.
For more information about our research interests, please visit the Bouvier lab website.
Rialdi A, Campisi L, Zhao N, Lagda AC, Pietzsch C, Ho JS, Martinez-Gil L, Fenouil R, Chen X, Edwards M, Metreveli G, Jordan S, Peralta Z, Munoz-Fontela C, Bouvier NM, Merad M, Jin J, Weirauch M, Heinz S, Benner C, van Bakel H, Basler C, García-Sastre A, Bukreyev A, Marazzi I. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation. Science 2016 May; 352(6289): aad7993.
Bouvier NM. Cystic fibrosis and the war for iron at the host-pathogen battlefront. Proceedings of the National Academy of Sciences of the United States of America 2016 Feb 113(6):1480-1482.
Bouvier NM. Animal models for influenza virus transmission studies: a historical perspective [review]. Current opinion in virology 2015 Aug; 13: 101-108.
Varble A, Albrecht RA, Backes S, Crumiller M, Bouvier NM, Sachs D, García-Sastre A, tenOever BR. Influenza A virus transmission bottlenecks are defined by infection route and recipient host. Cell host & microbe 2014 Nov; 16(5): 691-700.
Lowen AC, Bouvier NM, Steel J. Transmission in the Guinea Pig Model [review]. Current topics in microbiology and immunology 2014 Jul;(385): 157-183.
Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, Krammer F, Solórzano A, García-Sastre A, Palese P, Bouvier NM. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nature Communications 2013 Dec; 4: 2854.
Bouvier NM, Rahmat S, Pica N. Enhanced Mammalian Transmissibility of Seasonal Influenza A/H1N1 Viruses Encoding an Oseltamivir-Resistant Neuraminidase. Journal of virology 2012 Jul; 86(13): 7268-7279.
Bouvier NM. The science of security versus the security of science [editorial]. The Journal of infectious diseases 2012 Jun; 205(11): 1632-1635.
Thangavel RR, Bouvier NM. Animal models for influenza virus pathogenesis, transmission, and immunology [review]. Journal of Immunological Methods 2014; 410: 60-79.
Seibert CW, Rahmat S, Krammer F, Palese P, Bouvier NM. Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistance. Journal of virology 2012 May; 86(9): 5386-5389.
Bouvier NM, Lowen AC, Palese P. Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. Journal of virology 2008 Oct; 82(20): 10052-10058.